Accelerate Diagnostics Inc recalls Accelerate PhenoTest BC kit REF 10101018
- Recall date
- October 17, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0345-2023
- FDA classification
- Class II
- Brand / firm
- Accelerate Diagnostics Inc
- Sold / distributed
- U.S.: AR, CA, DC, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, ME, MN, MO, MS, MT, NC, ND, NJ, NY, OH, PA, RI, SC, TN, TX, VA, WA, and WV. O.U.S.: Germany, Italy, Kuwait, Latvia, Poland, Portugal, Romania, Saudi Arabia, Spain, and United Arab Emirates
Why it was recalled
Due improperly formulated and released bulk lot of fluorescence in situ hybridization (FISH) probes resulting in false positive identification results for Staphylococcus aureus and Streptococcus spp.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Accelerate PhenoTest BC kit REF 10101018
Get recall alerts
Free email alert whenever Accelerate Diagnostics Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Accelerate Diagnostics Inc